The Use of Cannabinoids in Treating Dementia-Reference-Cited by-同舟云学术

The Use of Cannabinoids in Treating Dementia

Published:2017-06-19 Issue:8 Volume:17 Page:
ISSN:1528-4042
Container-title:Current Neurology and Neuroscience Reports
language:en
Short-container-title:Curr Neurol Neurosci Rep

Author:

Weier Megan,Hall Wayne

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Neuroscience

Link

http://link.springer.com/article/10.1007/s11910-017-0766-6/fulltext.html

Reference49 articles.

1. Eastwood R, Reisberg B. Mood and behaviour. In: Gauthier S, editor. Clinical diagnosis and management of Alzheimer’s disease. London: Martin Dunitz; 1996. p. 175–89.

2. Rojas-Fernandez CH, Lanctôt KL, Allen DD, MacKnight C. Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm? Pharmacotherapy. 2001;21(1):74–102.

3. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293(5):596–608.

4. Ballard CG, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer’s disease. Cochrane Lib. 2006.

5. Lindsey PL. Psychotropic medication use among older adults: what all nurses need to know. J Gerontol Nurs. 2009;35(9):28–38.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Cannabinoid System in Alzheimer's Disease;Current Neuropharmacology;2023-03

2. Cannabinoids for Agitation in Alzheimer's Disease;The American Journal of Geriatric Psychiatry;2021-12

3. Cannabinoids for the treatment of dementia;Cochrane Database of Systematic Reviews;2021-09-17

4. Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review;Trends in Psychiatry and Psychotherapy;2021

5. Critical Review on the Chemical Aspects of Cannabidiol (CBD) and Harmonization of Computational Bioactivity Data;Current Medicinal Chemistry;2020-12-30